BioNTech Falls Short In Jittery IPO Market

Investors also readjust to firm's unproven pipeline

 
• By Andrew McConaghie
  
Cautioin
Investors wary of jumping into public offerings • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip